ZBIO

ProShares UltraPro Short NASDAQ Biotechnology

Delisted

ZBIO was delisted on the 27th of March, 2020.

5 hedge funds and large institutions have $468K invested in ProShares UltraPro Short NASDAQ Biotechnology in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Citadel Advisors
1
Citadel Advisors
Florida
$286K -$14.7K -1,094 -5%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$136K +$136K +10,082 New
UBS Group
3
UBS Group
Switzerland
$28K -$27.2K -2,040 -49%
Morgan Stanley
4
Morgan Stanley
New York
$13K +$10.1K +768 +343%
CG
5
Cutler Group
California
$5K +$5K +399 New
Jane Street
6
Jane Street
New York
-$176K -13,247 Closed
VF
7
Virtu Financial
New York
-$169K -12,754 Closed
TRCT
8
Tower Research Capital (TRC)
New York
-$1K -47 Closed